How can pharma sponsors can successfully navigate the critically important early phase development of their oncology therapies? With 2023’s new FDA Guidance for Dosage Optimization in Oncology Treatment (known as Project Optimus) and the increasingly complex and varied oncology therapies landscape, smart trial design is essential to finding success. Download your free article to discover: